生物制造
生物
计算生物学
雅罗维亚
生物技术
合成生物学
酵母
系统生物学
杠杆(统计)
模式生物
工作流程
分离(微生物学)
酿酒酵母
基因组编辑
数据科学
人类健康
清脆的
药物发现
模块化设计
多路复用
云计算
蓝图
克隆(编程)
代谢工程
生物信息学
计算机科学
非核糖体肽
生物过程
转化研究
敏捷软件开发
人类疾病
工程类
作者
Sangdo Yook,Jae Won Lee,Myungseo Park,Hyun Gi Koh,Jonghyeok Shin
标识
DOI:10.1093/femsyr/foag058
摘要
Yeast platforms are rapidly transitioning from traditional eukaryotic model organisms to versatile, programmable chassis for next-generation human health applications. This review systematically examines the translational evolution of conventional and non-conventional yeasts including Saccharomyces cerevisiae, Komagataella phaffii, Saccharomyces boulardii, and Yarrowia lipolytica and redefines them as scalable biomanufacturing factories and advanced living therapeutics. We highlight milestone advancements in synthetic biology toolkits that lower technical barriers, such as CRISPR-mediated multiplex editing, modular cloning frameworks, and high-throughput secretion screening. We focus on sophisticated glycoengineering strategies for humanized N-glycosylation, alongside data-driven paradigms that leverage artificial intelligence to predict gene expression and streamline strain design. In clinical domains, we detail the established success of yeast in producing subunit or virus-like particle vaccines (e.g. HBV and HPV) and therapeutic enzymes (e.g. ecallantide), alongside its emerging role as gut-adapted live biotherapeutic products (LBPs) engineered for in situ delivery and biosensing. Finally, we explore specialized non-conventional platforms, focusing on lipid- and acetyl-CoA-rich hosts for lipophilic drug discovery, and stress-tolerant systems optimized for economical, feedstock-flexible bioprocesses. In summary, this review underscores the integrated value of yeast systems across disease modeling, industrial manufacturing, and clinical intervention, charting future directions to address global health challenges.
科研通智能强力驱动
Strongly Powered by AbleSci AI